Abstracts

Elvitegravir Reduces Monocyte Activation and Vascular Inflammation More Than Efavirenz

Background: Heightened inflammation and monocyte activation may drive cardiovascular disease and other comorbidities in HIV. Little is known about the differential effects of antiretrovirals on immune activation. Methods: A randomized, double blind trial in ART-naïve HIV-infected adults comparing safety and efficacy of elvitegravir/cobicistat/emtricitabine/tenofovir (EVG/C/F/TDF) and efavirenz/emtricitabine/tenofovir (EFV/F/TDF) was previously performed. From a random sample of…

Impact of Antiretroviral Drugs on Hypertension in HIV-Positive Persons: D:A:D Study

Background: Previous studies have documented that hypertension in HIV-positive (HIV+) individuals is associated with traditional risk factors such as older age, male gender, diabetes, dyslipidemia and high body mass index (BMI). However, controversy remains as to whether the exposure to antiretroviral therapy (ART) poses additional risk. We investigated this issue in the D:A:D Study. Methods:…

Population-Based Assessment of Hypertension Among HIV Patients in Rural Uganda

Background: Background: Following ART scale-up, there is an aging HIV+ population at risk for non-communicable diseases such as hypertension (HTN). We estimated HTN prevalence among adults ≥18 years attending multi-disease health campaigns in 20 rural Ugandan communities in the SEARCH Study (NCT01864603). We investigated (a) HIV as an independent risk factor for HTN, given conflicting…

CD4/CD8 Ratio, Age, and Serious Noninfectious Outcomes in HIV-Infected Adults

Background: In virologically suppressed HIV-infected adults, CD4/CD8 ratio has been inversely associated with risk of non-communicable diseases (NCDs). Very low CD4/CD8 ratio (<0.4) despite antiretroviral therapy (ART) also correlates with higher measures of immunosenescence. The interaction of age and CD4/CD8 and its association with future NCD events has not been described. Methods: We assessed the…

Relationship Between Confirmed eGFR and Cardiovascular Disease in HIV-Positive Persons

Background: While the association between impaired kidney function and cardiovascular disease (CVD) is well established in the general population, this association remains poorly elucidated in HIV-positive individuals. As prior studies in HIV have focused on unconfirmed measures of kidney function, which are subject to random variation and acute illness, the influence of sustained kidney impairment…

Smoking, Other Substance Use and Coronary Atherosclerosis Among HIV-Infected and Uninfected Men

Background: HIV infection is associated with subclinical atherosclerosis. Recreational substance use is prevalent among HIV-infected (HIV+) persons. Associations between substance use and coronary plaque by HIV serostatus are not well-characterized. Methods: We studied 1005 men who have sex with men in the Multicenter AIDS Cohort Study (612 HIV+ and 384 HIV-uninfected [HIV-]), all of whom…

Pericardial Fat Density: A Novel Marker of Cardiometabolic Risk in HIV Infection

Background: Pericardial fat volume is associated with inflammation, insulin resistance, and vascular disease in HIV-infected patients on antiretroviral therapy (ART). The relationship between pericardial fat density, inflammation, and cardiometabolic risk in this population is unknown. Methods: Pericardial fat volume and density [mean Hounsfield Units (HU)] were measured by cardiac computed tomography in 147 HIV-infected patients…

The Effect of Physical Activity on Cardiometabolic Health and Inflammation in HIV

Background: In HIV-uninfected populations, physical activity decreases mortality and reduces inflammation. Persistent inflammation is a potential cause for increased co-morbidities in HIV+ adults, yet the evidence examining the effect of physical activity on cardiometabolic health and inflammation in this population is limited. This analysis examines the relationship between physical activity and markers of cardiometabolic health…

Abacavir Use and Risk for Myocardial Infarction in the NA-ACCORD

Background: Whether abacavir (ABC) exposure contributes to myocardial infarction (MI) risk remains unclear. Large observational studies, including D:A:D, found ABC use associated with nearly 2-fold increased MI risk; other studies have found no association. We evaluated MI risk associated with recent ABC use among patients in the largest North American cohort study: NA-ACCORD. Methods: Incident…

IL-6 and CD8 Senescence Independently Associate With Atherosclerosis in Treated HIV

Background: Increased cardiovascular (CV) risk persists among patients with treated HIV disease, and chronic immune activation is thought to contribute to this excess risk. Carotid intima-media thickness (CIMT) assesses atherosclerotic burden and predicts future CV events. We studied the immunologic correlates of CIMT in patients on ART with suppressed viral load (VL). Methods: Cryopreserved mononuclear…